Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
American Society of Clinical Oncology
Isala
QuantumLeap Healthcare Collaborative
Institut Curie
Deraya University
Cancer Research UK
Cancer Research UK
SOLTI Breast Cancer Research Group
ALX Oncology Inc.
Rigshospitalet, Denmark
Suzhou Teligene Ltd.
Genentech, Inc.
Puma Biotechnology, Inc.
Samsung Bioepis Co., Ltd.
The Netherlands Cancer Institute
Institut CatalĂ d'Oncologia
Amgen
Shanghai Changzheng Hospital
NKGen Biotech, Inc.
Novartis
National Cancer Institute (NCI)
Novartis
Merck Sharp & Dohme LLC
Instituto Nacional de Cancer, Brazil
Hoffmann-La Roche
Hoffmann-La Roche
Berufsverband Niedergelassener GynÀkologischer Onkologen in Deutschland e.V.
Meiji Seika Pharma Co., Ltd.
BBB-Therapeutics B.V.
GlaxoSmithKline
University of California, San Francisco
Hellenic Oncology Research Group
National Cancer Institute (NCI)
Pfizer
Hellenic Oncology Research Group
Pfizer
Sanofi
National Institutes of Health Clinical Center (CC)